Skip to content

Bergamot

A citrus polyphenol extract with strong evidence for improving cholesterol and metabolic markers — a natural lipid-support option.

  • CategoryCardiovascular
  • FormCitrus bergamot extract
  • EvidenceClinical trials on file

Where to get Bergamot

iHerb
Citrus bergamot extract

Cam’s partner link opens iHerb on this product. No code needed; the link credits Cam.

Shop on iHerb

The short version

  • What it doesBergamot is the one supplement in this category with a real pharmacophore rather than a vibe, and the pharmacophore has a name. Citrus bergamia juice carries the ordinary citrus flavanone glycosides — neoeriocitrin, naringin, neohesperidin — and then two molecules almost nothing else in the plant kingdom has: brutieridin and melitidin.
  • Who it is forCholesterol, triglyceride and metabolic support.
  • What to watchWell tolerated; GI upset and heartburn are the usual reports.

How Bergamot works

Citrus bergamot polyphenols — brutieridin and melitidin — are structurally similar to statins and appear to weakly inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. Separately they activate AMPK, which suppresses hepatic lipogenesis, and improve glucose handling.

Read the rest of how it works

That dual action is why bergamot moves triglycerides and glucose alongside LDL rather than LDL alone.

Bergamot: serving, timing and spacing

Suggested serving
500–1,000 mg standardized extract daily.
How often
Daily
When
With the evening meal - cholesterol synthesis peaks overnight, which is also why statins are dosed at night

General referenceA general reference intake for education, not a prescription. The label on the product you buy is the final word.

Good to know: A well-evidenced natural cholesterol option — stacks with omega-3 and diet.

Research on Bergamot4 evidence notes: clinical, correlative, theoretical

Each note sits under the kind of evidence it stands on. A thin or missing trial means nobody has run it yet, not that it doesn’t work. How the evidence tiers work

Human clinical evidence

  • Meta-analyses show reduced total and LDL cholesterol and triglycerides, with raised HDL.

  • Also improves some glucose/insulin markers.

Correlative data

  • Its polyphenols act on the same lipid pathways as statins (HMG-CoA), more gently.

Theoretical / extrapolated benefits

  • A statin-adjacent mechanism without statin side effects — promising, growing evidence.

Sources read for this page

  • Mollace V, et al. Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies.. Fitoterapia 2011 · PMID 21056640
  • Gliozzi M, et al. Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia.. International Journal of Cardiology 2013 · PMID 24239156
  • Huang Y, et al. Defining the Cholesterol Lowering Mechanism of Bergamot (Citrus bergamia) Extract in HepG2 and Caco-2 Cells. Nutrients 2021 · PMID 34579033
  • Rondanelli M, et al. Bergamot phytosome improved visceral fat and plasma lipid profiles in overweight and obese class I subject with mild hypercholesterolemia: A randomized placebo controlled trial. Phytotherapy Research 2021 · PMID 33188552
  • Carresi C, et al. The Effect of Natural Antioxidants in the Development of Metabolic Syndrome: Focus on Bergamot Polyphenolic Fraction. Nutrients 2020 · PMID 32455840
  • He K, et al. Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice.. Chemical Research in Toxicology 1998 · PMID 9548795

Bergamot, the deep readThe mechanism, cell to human, which form, how you would know

What Bergamot actually does

Bergamot is the one supplement in this category with a real pharmacophore rather than a vibe, and the pharmacophore has a name. Citrus bergamia juice carries the ordinary citrus flavanone glycosides — neoeriocitrin, naringin, neohesperidin — and then two molecules almost nothing else in the plant kingdom has: brutieridin and melitidin. Each is a flavanone glycoside carrying a 3-hydroxy-3-methylglutaryl group. That HMG moiety is the same fragment that sits at the business end of every statin, because it is the structural mimic of HMG-CoA, the substrate of HMG-CoA reductase. This is not a metaphor about “acting on the same pathway”; it is the same chemical group on a different scaffold.

What the cell work actually shows, and it is two mechanisms not one. In HepG2 hepatocytes and Caco-2 intestinal cells, bergamot extract lowers total and free cellular cholesterol and reduces HMGCR expression — note expression, meaning the amount of reductase protein transcribed, which is a different lever from a statin's direct active-site inhibition. Separately, brutieridin reduces cholesterol uptake in the Caco-2 monolayer Huang 2021. Caco-2 uptake is the enterocyte-absorption compartment, which is NPC1L1 territory — the ezetimibe target. So bergamot has a synthesis-side argument and an absorption-side argument, and they predict different things about who responds.

The vascular arm is a receptor, and it is named. In hyperlipidemic patients, adding bergamot to rosuvastatin reduced malondialdehyde and reduced expression of LOX-1 — the lectin-like oxidized-LDL receptor, gene OLR1, the endothelial scavenger receptor that takes up oxidized LDL and drives the endothelial dysfunction step of plaque initiation — alongside changed phosphorylation of protein kinase B Gliozzi 2013. That is a mechanistically distinct claim from lowering LDL: it says the particles that remain are being handled differently at the vessel wall.

And there is a second chemistry in this plant that has nothing to do with any of it. The peel oil of bergamot is the source of bergamottin, a furanocoumarin that inactivates cytochrome P450 3A4 by mechanism-based (suicide) inhibition — the reaction behind the grapefruit-juice effect He 1998. Furanocoumarins live in the oil; the lipid-lowering polyphenols live in the juice. A product can contain either, both or neither, and the label almost never says. Hold that thought until the safety section, because it is the whole statin interaction.

Cell, rodent, human — and where it stops

In cells. HepG2 and Caco-2 monolayers, bergamot extract and isolated components, cellular cholesterol and HMGCR expression down, brutieridin blocking uptake Huang 2021. Standard flavonoid cell-culture concentrations run in the tens of micromolar.

In rodents. Hyperlipidemic-diet rats given bergamot polyphenolic fraction, with reductions in cholesterol and triglycerides and reported inhibition of HMG-CoA reductase in the animal arm of the same paper that carries the human data Mollace 2011; the wider preclinical metabolic-syndrome literature is collected in Carresi 2020.

In people, and this is the reason bergamot is not filed with the hopefuls. Two hundred and thirty-seven hyperlipidemic patients took bergamot polyphenolic fraction by mouth for 30 days, with total and LDL cholesterol down, HDL up, and triglycerides and blood glucose down Mollace 2011. Seventy-seven hyperlipidemic patients were assigned rosuvastatin 10 or 20 mg, bergamot 1,000 mg, or the combination for 30 days; the combination beat the statin alone on LDL-C and on the oxidative and LOX-1 read-outs Gliozzi 2013. Sixty-four overweight and obese adults with mild hypercholesterolemia took a bergamot phytosome 500 mg twice daily against placebo for 12 weeks, with visceral adipose tissue and total and LDL cholesterol down by 30 days — and, importantly, other metabolic parameters unchanged Rondanelli 2021.

The specific obstacle is that the evidence belongs to a fraction and the shelf sells a genus. Every trial above used a defined preparation: a polyphenolic fraction from the juice Mollace 2011, or a phospholipid-complexed phytosome of it Rondanelli 2021. Neither is “bergamot extract”, and neither is bergamot juice, and neither is bergamot essential oil. The brutieridin and melitidin content is what the mechanism argument rests on Huang 2021, and a bottle that does not quantify total flavanones has not told you whether it contains any.

The second obstacle is trial architecture. The statin-combination study was open-label and parallel-group Gliozzi 2013; the 237-patient study is reported inside a paper that also carries the animal work Mollace 2011. The cleanest design in the set is the 64-person double-blind phytosome trial, and it is the one whose effects were confined to lipids and visceral fat with everything else flat Rondanelli 2021. As trials get tighter the claim gets narrower, which is the ordinary trajectory and should be expected to continue.

Bergamot — which form, and does it matter

Bergamot polyphenolic fraction is a specification. “Citrus bergamot extract” is a plant name. BPF is prepared from the juice and characterized by its flavanone glycoside content, with brutieridin and melitidin as the distinctive markers Huang 2021Carresi 2020. If a label states a total flavanone percentage, or names BPF, you can map it onto the trials. If it says “bergamot fruit extract 500 mg” and nothing else, you cannot, and the honest position is that you do not know what is in it.

Juice fraction versus peel oil is the distinction that matters most and is printed least. Cold-pressed bergamot peel oil is the Earl Gray ingredient and the perfumery ingredient. It is rich in bergapten (5-methoxypsoralen) and bergamottin, and it is where the CYP3A4 and phototoxicity problems live He 1998. The lipid-lowering polyphenols are in the juice, not the oil. A supplement described only as “bergamot” may be either.

Phytosome is a different exposure, not a marketing word. The 12-week trial used a phospholipid complex at 500 mg twice daily Rondanelli 2021, while the statin-combination work used 1,000 mg of the fraction Gliozzi 2013. Flavanone glycosides are poorly absorbed as glycosides — the sugar has to come off, usually by gut bacteria, before the aglycone is taken up. A phospholipid complex changes that step, so milligram-for-milligram comparisons between a phytosome and a plain fraction are not meaningful.

The dose that appears in the trials is 500–1,000 mg/day and the split matters. The double-blind trial split it Rondanelli 2021. Given that the absorption step depends on microbial deglycosylation in the colon, a split dose keeps the colon supplied rather than saturating it once, which is a reasoned extrapolation and is labeled as one.

What would have to be true, and how you would know it was not

1. ApoB down 8–15% by 8–12 weeks at 500 mg twice daily of a characterized fraction. ApoB, not LDL-C, because bergamot's own trial base reports movement in HDL and triglycerides simultaneously Mollace 2011, and when several lipid fractions move at once the particle count is the only number that stays interpretable. Twelve weeks because the LDL pool re-equilibrates in about three weeks and the phytosome trial saw its effect by day 30 Rondanelli 2021.

2. If the LOX-1 arm is real, hs-CRP should move and it should move late. Receptor-level changes at the endothelium show up as inflammation markers, not as lipids. Predict hs-CRP down 0.3–1.0 mg/L at 12 weeks in someone starting above 2 mg/L, and predict it lags the lipid change by weeks Gliozzi 2013. A product that moves LDL and leaves CRP exactly where it was has done the synthesis half and not the vessel-wall half.

3. The prediction that cuts against the product. Lp(a) will not move. It is made and cleared largely independently of the LDL pathway, it is set genetically, and nothing in the bergamot mechanism touches apolipoprotein(a) synthesis. So a reader whose cardiovascular risk is being driven by an Lp(a) of 150 nmol/L should understand that this product cannot address it, and that a satisfying fall in LDL-C on the same report is not the same news. Predict Lp(a) unchanged within assay variation at 12 weeks — and if it does fall by more than 20%, that is a genuinely novel finding worth a doctor's attention rather than a win.

4. Fasting glucose down 3–8 mg/dL, or nothing at all, depending on baseline. The 237-patient report includes glucose Mollace 2011; the tighter 64-person trial found the other metabolic parameters unchanged Rondanelli 2021. Predict the tight trial is closer to the truth in a normoglycemic reader, and that any glucose effect is confined to people who start dysglycemic.

What will fool you: a new muscle ache three weeks in reads as “statin-like effect, must be working”. If you are taking a statin as well, that is the interaction in the safety section and it is worth a creatine kinase, not a shrug.

What nobody has tested yet

Nobody has quantified brutieridin and melitidin in a commercial capsule and then correlated it with response. That is the experiment. The mechanism argument names these two molecules Huang 2021; the trials use fractions whose content is defined in the paper and nowhere on a shelf. Assay ten retail bottles, dose thirty people from each for eight weeks, and plot ApoB change against measured HMG-flavanone content. If the line has a slope, the mechanism is confirmed and label standardization becomes mandatory. If it is flat, the active is something else in the fraction and everybody has been marketing the wrong molecule.

The synthesis-versus-absorption question is unanswered and cheap. Bergamot has a Caco-2 uptake effect and an HMGCR-expression effect in the same paper Huang 2021. Serum lathosterol and desmosterol (synthesis) against campesterol and sitosterol (absorption), before and after 30 days, would say which one dominates in a living person. If it is absorption, bergamot should stack additively with a statin and redundantly with ezetimibe — a clinically useful, entirely untested prediction.

No trial has combined bergamot with a CYP3A4-dependent statin. The one combination trial used rosuvastatin Gliozzi 2013, which is the statin least dependent on CYP3A4 for its clearance. Simvastatin and atorvastatin are the ones a furanocoumarin would actually collide with He 1998, and nobody has run that combination under measurement. The missing experiment is a pharmacokinetic study: simvastatin AUC with and without a defined bergamot product, with the product's furanocoumarin content measured rather than assumed.

And no bergamot trial has ever run long enough to touch an outcome. Thirty days Mollace 2011Gliozzi 2013, twelve weeks Rondanelli 2021. Carotid intima-media thickness over 24 months, or coronary calcium progression, is what a lipid claim eventually has to answer to, and nobody has attempted it.

Bergamot — its own safety story, not its category's

The statin question, answered properly rather than with a warning label. There are two separate interactions and they run in opposite directions. The first is pharmacodynamic and it is the one the trial was designed around: bergamot plus rosuvastatin lowered LDL-C more than rosuvastatin alone Gliozzi 2013, which is the intended, additive, useful version. The second is pharmacokinetic and nobody planned for it: if a bergamot product carries peel-derived furanocoumarins, bergamottin inactivates CYP3A4 He 1998, and simvastatin, lovastatin and to a lesser degree atorvastatin are cleared through CYP3A4. Inhibiting it raises statin exposure, and raised statin exposure is exactly how statin myopathy and rhabdomyolysis happen. Rosuvastatin and pravastatin are largely spared. Read that sequence again: the only published combination trial used the one statin where this interaction is least likely to appear.

What to do about it, concretely. If you take simvastatin, lovastatin or atorvastatin and want to add bergamot, ask the manufacturer in writing whether the product is furanocoumarin-free and at what limit of detection. If the answer is vague, treat the product as grapefruit and behave accordingly. Baseline creatine kinase and a repeat at six weeks costs almost nothing and turns a theoretical interaction into a number.

Phototoxicity, which is a bergamot-specific risk and not a citrus-generic one. Bergapten (5-methoxypsoralen) from the peel is a photosensitizer — it is the reason bergamot oil is restricted in leave-on cosmetics. Oral exposure at supplement doses is a much smaller question than topical, but if a product is oil-derived rather than juice-derived and you are also using a phototherapy lamp, a tanning bed or a photosensitizing drug such as a tetracycline or amiodarone, that is a stack worth avoiding.

Heartburn is the common complaint and it has a cause. This is a concentrated citrus flavanone preparation; reflux and epigastric burning are the usual adverse events, and they are dose- and timing-dependent rather than idiosyncratic. Taking it with food, split twice daily, is the fix.

And the boundary. The trials ran 30 days to 12 weeks in people with mild hypercholesterolemia and metabolic syndrome Mollace 2011Rondanelli 2021. There is no outcome data, no long-term safety data past a few months, and no trial in anyone with established coronary disease. Where a statin is indicated — prior event, familial hypercholesterolemia, a high calcium score — this is an addition, not a substitution, and the trial base itself is built that way.

Bergamot safety basics3 points of its own

Its own safety story

  • Well tolerated; GI upset and heartburn are the usual reports.
  • Contains the same statin-like and CYP3A4-inhibiting chemistry as its citrus relatives — caution alongside statins, and muscle pain is a reported effect.
  • Additive with lipid-lowering and blood-pressure medication. Not established as safe in pregnancy or breastfeeding — not because harm is documented, but because these are the two populations systematically excluded from the trials. Absence of data is not reassurance.

Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor. Pharmacists are underused and free.

Bloodwork to run5 tests in one order, code CAMERON

Bergamot FAQ5 common questions

What is Bergamot?
A citrus polyphenol extract with strong evidence for improving cholesterol and metabolic markers — a natural lipid-support option.
What is the suggested dose of Bergamot?
500–1,000 mg standardized extract daily. This is a general reference for education only. Statements have not been evaluated by the FDA and this is not medical advice.
Who is Bergamot for?
Cholesterol, triglyceride and metabolic support.
Which labs show whether Bergamot is doing anything?
ApoB (Apolipoprotein B), Lipoprotein(a) — Lp(a), hs-CRP (High-Sensitivity C-Reactive Protein), Lipid Panel (Cholesterol, HDL, LDL, Triglycerides), HbA1c (Hemoglobin A1c). Draw a baseline before you start, then recheck.
Where can I buy Bergamot?
Coach Cam sources Bergamot from vetted, top-rated brands on iHerb. Use the buy link on this page.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

The full stack plan is inside Skool

This page covers what Bergamot is, what the research says and how people take it. Skool puts it in order alongside everything else you run, peptides included.

Free on this page

What Bergamot is and how it works · The serving, its basis, and its safety lines · The research and the bloodwork that shows it

  • What Bergamot is and how it works
  • The serving, its basis, and its safety lines
  • The research and the bloodwork that shows it

Members get

  • Bergamot in your full stack: what it runs with, and what it cancels out
  • Its place in 2 Protocol Blueprints (Longevity, Cardiovascular), week by week
  • The retest plan: ApoB (Apolipoprotein B) baseline, the recheck, what a change means
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational reference only. Not medical advice. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure or prevent any disease. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy on iHerbJoin Skool